Overprescribing of psychotropics for adults with autism
Adults on the autism spectrum are often prescribed psychotropic medication to manage behaviour, despite limited evidence to support this practice, a new report has...
Cost of asthma treatment – a deterrent to use
Cost is a major factor associated with non-adherence to asthma treatment in Australia, recent research revealed. Healthcare providers can assist patients with adherence by...
The long road to remunerated consultations
Like the great plague of 1665, the COVID-19 pandemic has demonstrated the value of pharmacists, and accelerated practice evolution.
RACGP on dispensing during disasters
The Royal Australian College of General Practitioners (RACGP) has supported PSA’s call for better dispensing authorities without prescriptions for people with chronic disease during...
Systemic corticosteroids for dyspnoea
The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer.
Dyspnoea affects almost 70% of advanced cancer patients at the...
PSA National President opening address at PSA24
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).
